Drug firm Alembic Pharmaceuticals on Friday said it has raised ₹350 crore through allotment of non-convertible debentures (NCDs) on private placement basis.
“The NCD committee of Alembic Pharmaceuticals Ltd has allotted 1,500, 9 per cent rated unsecured listed redeemable non-convertible debentures (NCDs)... aggregating to ₹150 crore under tranche I,” Alembic Pharmaceuticals said in a regulatory filing.
The company said it has also allotted 2,000, 9 per cent rated unsecured listed redeemable NCDs aggregating to ₹200 crore.
Shares of Alembic Pharmaceuticals were trading 0.42 per cent lower at ₹615 on BSE.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.